Esophageal lesions at irritable bowel syndrome

Esophageal lesions at irritable bowel syndrome

Aim of investigation. To study potential of рН-impedance measurement in differential diagnostics of esophageal disorders at irritable bowel syndrome (IBS).Material and methods. Overall 201 patients with IBS, diagnosed according to Rome-III criteria were investigated. Of them 52 were men, 149 — women...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. G. Mnatsakanyan, O. V. Tashchyan, Yu. A. Morozova, A. P. Pogromov, G. M. Dyukova, D. V. Khalyapina
Format:	Article
Language:	Russian
Published:	Gastro LLC 2015-10-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	combined рн-impedance recording non-erosive reflux disease functional disorders of the esophagus and the stomach irritable bowel syndrome
Online Access:	https://www.gastro-j.ru/jour/article/view/1065
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Potentials of intraesophageal рН-impedance measurement in GERD diagnostics
by: V. O. Kaybysheva, et al.
Published: (2013-05-01)

Options of improvement of efficacy of gastroesophageal reflux disease treatment by dioctaedric smectite
by: O. A. Storonova, et al.
Published: (2015-10-01)

The Role of Duodenogastroesophageal Reflux in the Progression of Gastroesophageal Reflux Disease: From Esophagitis to Adenocarcinoma
by: O. A. Storonova, et al.
Published: (2024-08-01)

Indicators of Esophageal pH-Impedance Monitoring and High-Resolution Manometry in Patients with Various Forms of Gastroesophageal Reflux Disease
by: I. V. Maev, et al.
Published: (2018-09-01)

Improvement of gastroesophageal reflux disease diagnostics in pediatrics
by: S. I. Erdes, et al.
Published: (2014-10-01)

Features of the Parameters of 24-Hours pH-Impedance and High-Resolution Esophageal Manometry in Patients with Barrett's Esophagus on Proton Pump Inhibitors
by: I. V. Maev, et al.
Published: (2023-06-01)

Recommendations of the Russian Gastroenterological Association in Diagnosis and Treatment of Gastroesophageal Reflux Disease
by: V. T. Ivashkin, et al.
Published: (2020-09-01)

Irritable Bowel Syndrome Onset after New Coronavirus Infection COVID-19
by: I. Yu. Feklina, et al.
Published: (2022-03-01)

Whether pH-metry and investigation of esophageal motor function are necessary for diagnosis and choice of therapy for us today?
by: O. A. Storonova, et al.
Published: (2010-04-01)

Prognosis of erosions development at gastric metaplasia of esophageal mucosa in patients with gastroesophageal reflux disease
by: Ye. K. Mastykova, et al.
Published: (2012-11-01)

Diagnosis and Treatment of Gastroesophageal Reflux Disease (Clinical Guidelines of the Russian Gastroenterological Association, Russian Scientific Medical Society of Internal Medicine, Russian Society for the Prevention of Noncommunicable Diseases, Scientific Community for Human Microbiome Research)
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Discussion of gastroesophageal reflux disease issue in World gastroenterological congress abstracts (Shanghai, 2013)
by: V. O. Kaybysheva, et al.
Published: (2014-09-01)

Psychological and autonomous nervous system features of functional gastric dyspepsia and irritable bowel syndrome, duloxetine treatment efficacy
by: A. P. Pogromov, et al.
Published: (2012-06-01)

Features of the Expression of Second-Type Melatonin Receptors by Esophagus Epiteliocytes in Gastroesophageal Reflux Disease
by: O. A. Karpovich, et al.
Published: (2020-05-01)

Pathogenetic Substantiation of the Therapeutic Impact on Microbiota in Irritable Bowel Syndrome
by: Yu. O. Shulpekova, et al.
Published: (2019-09-01)

Diagnosis and Treatment of Irritable Bowel Syndrome: Clinical Recommendations of the Russian Gastroenterological Association and Association of Coloproctologists of Russia
by: V. T. Ivashkin, et al.
Published: (2022-01-01)

Combination of functional dyspepsia syndrome and irritable bowel syndrome
by: V. T. Ivashkin, et al.
Published: (2011-06-01)

Features of nervous system in children with irritable bowel syndrome
by: O. K. Botvin’yev, et al.
Published: (2011-12-01)

Irritable Bowel Syndrome Diagnosis: Should There Be Alertness to Cancer?
by: A. A. Sheptulin, et al.
Published: (2019-05-01)

Role of nutritional factors at the irritable bowel syndrome
by: Yu. O. Shulpekova, et al.
Published: (2015-10-01)

COVID-19 Pandemic and Irritable Bowel Syndrome — is there a Relationship?
by: V. A. Akhmedov
Published: (2022-08-01)

The treatment of irritable bowel syndrome from the modern views on the disease pathogenesis
by: Ye. A. Poluektova, et al.
Published: (2013-03-01)

Use of Bismuth in Irritable Bowel Syndrome
by: T. A. Ilchishina
Published: (2021-10-01)

Diagnosis of Columnar Metaplasia of the Esophageal Mucosa in Patients with Complicated Gastroesophageal Reflux Disease
by: E. D. Fedorov, et al.
Published: (2024-03-01)

Irritable Bowel Syndrome in Terms of Changes in the Microbiota
by: Vladimir T. Ivashkin, et al.
Published: (2019-03-01)

Interrelation of irritable bowel syndrome and bacterial overgrowth: is there any?
by: Yu. A. Kucheryavy, et al.
Published: (2014-08-01)

Postinfectious Irritable Bowel Syndrome: Polemic and Open Issues
by: A. A. Sheptulin, et al.
Published: (2022-03-01)

Acetylcholine in irritable bowel syndrome pathogenesis and the role of cholineblockers
by: Yu. O. Shulpekova
Published: (2011-02-01)

Irritable bowel syndrome: pathophysiological and clinical issues
by: V. T. Ivashkin, et al.
Published: (2015-03-01)

Effect of biofeedback – therapy on clinical semiology, quality of life and sensorimotor function of anorectal area at irritable bowel syndrome with refractory constipation
by: O. V. Krapivnaya
Published: (2014-07-01)

Combined alverine citrate and simeticonein preparation in the treatment of irritable bowel syndrome
by: Ye. A. Poluektova, et al.
Published: (2012-07-01)

Clinical impact of 24-hour pH-metry in esophageal and stomach diseases diagnostics and pharmacological drugs efficacy testing
by: A. S. Trukhmanov, et al.
Published: (2018-08-01)

Principles of portal hypertension treatment at patients with liver cirrhosis
by: Ye. A. Fedosina, et al.
Published: (2012-09-01)

Experience in the Treatment of Irritable Bowel Syndrome Developed after a New Coronavirus Infection (COVID-19)
by: R. G. Myazin
Published: (2022-05-01)

Kyoto International Consensus Report on Anatomy, Pathophysiology and Clinical Significance of the Gastroesophageal Junction
by: A. A. Sheptulin, et al.
Published: (2023-12-01)

Gastroesophageal Reflux Disease and Erosive-Ulcerative Lesions of the Gastroduodenal Zone in Schoolchildren of Various Ages in Siberia
by: E. V. Kasparov, et al.
Published: (2019-09-01)

The role of esophageal and stomach motility disorders in pathogenesis of gastroesophageal reflux disease
by: Yu. V. Yevsyutina, et al.
Published: (2015-10-01)

Irritable Bowel and Bacterial Overgrowth Syndromes: a Bacterial Link Hypothesis of Functional Disease
by: K. V. Ivashkin, et al.
Published: (2021-04-01)

Management of a Female Patient with Irritable Bowel Syndrome and Somatoform Disorder
by: E. A. Trush, et al.
Published: (2023-02-01)

Pathogenic role of intestinal microflora changes in patients with irritable bowel syndrome and treatment options
by: Ye. A. Poluektova, et al.
Published: (2014-09-01)